360 related articles for article (PubMed ID: 15864268)
1. Rho kinase, a promising drug target for neurological disorders.
Mueller BK; Mack H; Teusch N
Nat Rev Drug Discov; 2005 May; 4(5):387-98. PubMed ID: 15864268
[TBL] [Abstract][Full Text] [Related]
2. Organized migration of epithelial cells requires control of adhesion and protrusion through Rho kinase effectors.
Hopkins AM; Pineda AA; Winfree LM; Brown GT; Laukoetter MG; Nusrat A
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G806-17. PubMed ID: 17138966
[TBL] [Abstract][Full Text] [Related]
3. Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension.
Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
Drug News Perspect; 2006 Nov; 19(9):517-22. PubMed ID: 17220956
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic p21(Cip1/WAF1) enhances axonal regeneration and functional recovery after spinal cord injury in rats.
Tanaka H; Yamashita T; Yachi K; Fujiwara T; Yoshikawa H; Tohyama M
Neuroscience; 2004; 127(1):155-64. PubMed ID: 15219678
[TBL] [Abstract][Full Text] [Related]
5. Rho-kinase is an important therapeutic target in cardiovascular medicine.
Shimokawa H; Takeshita A
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1767-75. PubMed ID: 16002741
[TBL] [Abstract][Full Text] [Related]
6. E1AF/PEA3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of non-small-cell lung cancer cells.
Hakuma N; Kinoshita I; Shimizu Y; Yamazaki K; Yoshida K; Nishimura M; Dosaka-Akita H
Cancer Res; 2005 Dec; 65(23):10776-82. PubMed ID: 16322223
[TBL] [Abstract][Full Text] [Related]
7. The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration.
Lepley D; Paik JH; Hla T; Ferrer F
Cancer Res; 2005 May; 65(9):3788-95. PubMed ID: 15867375
[TBL] [Abstract][Full Text] [Related]
8. ROCK inhibition with Y27632 activates astrocytes and increases their expression of neurite growth-inhibitory chondroitin sulfate proteoglycans.
Chan CC; Wong AK; Liu J; Steeves JD; Tetzlaff W
Glia; 2007 Mar; 55(4):369-84. PubMed ID: 17136770
[TBL] [Abstract][Full Text] [Related]
9. Diverse signaling pathways regulate fibroblast differentiation and transformation through Rho kinase activation.
Harvey KA; Paranavitana CN; Zaloga GP; Siddiqui RA
J Cell Physiol; 2007 May; 211(2):353-63. PubMed ID: 17167780
[TBL] [Abstract][Full Text] [Related]
10. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.
Ohtsu H; Mifune M; Frank GD; Saito S; Inagami T; Kim-Mitsuyama S; Takuwa Y; Sasaki T; Rothstein JD; Suzuki H; Nakashima H; Woolfolk EA; Motley ED; Eguchi S
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1831-6. PubMed ID: 15994438
[TBL] [Abstract][Full Text] [Related]
11. Rho family-associated kinases PAK1 and rock.
Maruta H; Nheu TV; He H; Hirokawa Y
Prog Cell Cycle Res; 2003; 5():203-10. PubMed ID: 14593714
[TBL] [Abstract][Full Text] [Related]
12. Contraction of myofibroblasts in granulation tissue is dependent on Rho/Rho kinase/myosin light chain phosphatase activity.
Tomasek JJ; Vaughan MB; Kropp BP; Gabbiani G; Martin MD; Haaksma CJ; Hinz B
Wound Repair Regen; 2006; 14(3):313-20. PubMed ID: 16808810
[TBL] [Abstract][Full Text] [Related]
13. Screening for cell migration inhibitors via automated microscopy reveals a Rho-kinase inhibitor.
Yarrow JC; Totsukawa G; Charras GT; Mitchison TJ
Chem Biol; 2005 Mar; 12(3):385-95. PubMed ID: 15797222
[TBL] [Abstract][Full Text] [Related]
14. Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway.
Kozai T; Eto M; Yang Z; Shimokawa H; Lüscher TF
Cardiovasc Res; 2005 Dec; 68(3):475-82. PubMed ID: 16098957
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of ROCK by RhoE.
Riento K; Ridley AJ
Methods Enzymol; 2006; 406():533-41. PubMed ID: 16472685
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of the effects of Y-27632.
Darenfed H; Dayanandan B; Zhang T; Hsieh SH; Fournier AE; Mandato CA
Cell Motil Cytoskeleton; 2007 Feb; 64(2):97-109. PubMed ID: 17009325
[TBL] [Abstract][Full Text] [Related]
17. Melatonin induces neuritogenesis at early stages in N1E-115 cells through actin rearrangements via activation of protein kinase C and Rho-associated kinase.
Bellon A; Ortíz-López L; Ramírez-Rodríguez G; Antón-Tay F; Benítez-King G
J Pineal Res; 2007 Apr; 42(3):214-21. PubMed ID: 17349018
[TBL] [Abstract][Full Text] [Related]
18. Rho-kinase inhibitor, Y-27632, has an antinociceptive effect in mice.
Büyükafşar K; Yalçin I; Kurt AH; Tiftik RN; Sahan-Firat S; Aksu F
Eur J Pharmacol; 2006 Jul; 541(1-2):49-52. PubMed ID: 16750189
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Rho/ROCK signalling in small cell lung cancer migration through human brain microvascular endothelial cells.
Li B; Zhao WD; Tan ZM; Fang WG; Zhu L; Chen YH
FEBS Lett; 2006 Jul; 580(17):4252-60. PubMed ID: 16828752
[TBL] [Abstract][Full Text] [Related]
20. Rho kinase: a target for treating urinary bladder dysfunction?
Peters SL; Schmidt M; Michel MC
Trends Pharmacol Sci; 2006 Sep; 27(9):492-7. PubMed ID: 16870270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
